Once-monthly efimosfermin alfa prescribed for metabolic dysfunction–associated steatohepatitis with F2 and F3 fibrosis ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...

Use of the investigational drug efruxifermin did not significantly reduce fibrosis in patients with compensated cirrhosis ...

Target RWE, a leader in modern clinical evidence generation for complex diseases, today announced its presentations and strategic contributions at the EASL Congress 2025 in Amsterdam, Netherlands.

AMSTERDAM — A once daily, 50 mg dose of efruxifermin reduced fibrosis at 96 weeks in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH) compared with ...

If you’re looking for hints and answers for Strands for Saturday, May 10, 2025, read on—I’ll share some clues and tips, and ...

The publication reports results from the 96-week SYMMETRY study evaluating the efficacy and safety of Akero's lead FGF21 ...

Related: Costco's 'Sparkling' and 'Tangy' Summery Treat Has Fan's Racing to Stores: 'Need to Find These ASAP' ...

Jasson Dominguez hit three homers and drove in seven runs to lead the New York Yankees to a 10-2 victory over the Athletics on Friday night.

These include a series of bottled-in-bond vintage releases, and the details of the latest one were just announced.

The distilleries that populate the state have offerings for those who love history, nature, and of course the liquor.

With a quick scan of Factor's website and menu, it is quite clear the company is targeting the health, fitness and diet crowds. You will find lots of lean proteins like chicken and salmon along with ...